Helpful Links

References

  1. Establishing Safety and Compatibility of Passive Implants in the Magnetic Resonance (MR) Environment. U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health, 2014. www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/UCM107708.pdf
  2. American Association of Physicists in Medicine (AAPM) – Acceptance Testing and Quality Assurance Procedures for Magnetic Resonance Imaging Facilities: Report of MR Subcommittee Task Group I. Jackson, E., et al, 2010. www.aapm.org/pubs/reports/RPT_100.pdf
  3. American College of Radiology (ACR) – ACR Manual on Contrast Media (Version 9), 2013. www.acr.org/quality-safety/resources/contrast-manual
  4. Public Health Advisory: Update on Magnetic Resonance Imaging (MRI) Contrast Agents Containing Gadolinium and Nephrogenic Fibrosing Dermopathy. U.S. Department of Health and Human Services Food and Drug Administration, 2007. www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafety InformationforPatientsandProviders/ucm124344.htm
  5. United Council for Neurologic Subspecialties UCNS Recertification Requirements. www.ucns.org
  6. The American Society of Neuroimaging (ASNR) MRI/CT - Examination Information. www.asnweb.org/i4a/pages/index.cfm?pageid=3308
  7. American Association of Physicists in Medicine (AAPM) – Site Planning for Magnetic Resonance Imaging Systems: Report of AAPM NMR Task Group No. 2, Bronskill, M., et al, 1986. www.aapm.org/pubs/reports/RPT_20.pdf 11. MRI of the Pregnant Patient: Diagnostic and Management Challenges. International Society for Magnetic Resonance in Medicine (ISEMIR), Coakley, F., et al, 2011. cds.ismrm.org/protected/11MProceedings/files/ISMRM2011-8263.pdf